The U.S. diabetic foot ulcer treatment market size is anticipated to reach USD 2.47 billion by 2030, expanding at a CAGR of 5.25% from 2024 to 2030. The major factors contributing to market growth include the increasing occurrence of diabetes nationwide, an aging population, advancements in treatment technology, rising research and development efforts, and shifts in lifestyle patterns. For instance, according to the Population Reference Bureau's projections, the population of Americans aged 65 and older is expected to rise from 58 million in 2022 to 82 million by the year 2050, reflecting a 47% increase.
The prevalence of diabetes in the U.S. plays a significant role in market expansion, as diabetic foot ulcers are a common complication of the disease. For instance, according to the International Diabetes Federation, in 2021 there were about 32.21 million diabetes patients aged 20-79 years in the U.S. which are further expected to increase to 36.28 million by 2045. Furthermore, the advancements in medical technology and treatment modalities contribute to the growth of the market. Innovations such as advanced wound care products, bioengineered tissues, and regenerative medicine techniques offer more effective and efficient solutions for diabetic foot ulcer management.
Furthermore, the increasing awareness among healthcare providers and patients of the importance of early detection and proper treatment of diabetic foot ulcers is driving the market growth. Both healthcare professionals and patients understand the necessity of careful foot care and regular screenings to catch diabetic foot ulcers early. This heightened awareness encourages a proactive approach to managing complications of diabetes, leading to better outcomes for patients and fewer severe ulcers. Additionally, ongoing research and development efforts are essential in advancing treatment options and technologies for managing diabetic foot ulcers. These continued efforts result in innovative solutions, such as new therapies, diagnostic tools, and preventive measures, which expand the options available to healthcare providers.
Presence of major market participants and various initiatives undertaken by them to stay competitive in the market such as product approval, product launch, partnership, merger and acquisition, expansion, etc. are expected to contribute to the overall market growth. For instance, in April 2024, Molnlycke Health Care has announced its plans to acquire P.G.F. Industry Solutions GmbH, an Austrian company known for producing Granudacyn, a line of wound cleansing and moisturizing products.
This product will be delivered within 1-3 business days.
The prevalence of diabetes in the U.S. plays a significant role in market expansion, as diabetic foot ulcers are a common complication of the disease. For instance, according to the International Diabetes Federation, in 2021 there were about 32.21 million diabetes patients aged 20-79 years in the U.S. which are further expected to increase to 36.28 million by 2045. Furthermore, the advancements in medical technology and treatment modalities contribute to the growth of the market. Innovations such as advanced wound care products, bioengineered tissues, and regenerative medicine techniques offer more effective and efficient solutions for diabetic foot ulcer management.
Furthermore, the increasing awareness among healthcare providers and patients of the importance of early detection and proper treatment of diabetic foot ulcers is driving the market growth. Both healthcare professionals and patients understand the necessity of careful foot care and regular screenings to catch diabetic foot ulcers early. This heightened awareness encourages a proactive approach to managing complications of diabetes, leading to better outcomes for patients and fewer severe ulcers. Additionally, ongoing research and development efforts are essential in advancing treatment options and technologies for managing diabetic foot ulcers. These continued efforts result in innovative solutions, such as new therapies, diagnostic tools, and preventive measures, which expand the options available to healthcare providers.
Presence of major market participants and various initiatives undertaken by them to stay competitive in the market such as product approval, product launch, partnership, merger and acquisition, expansion, etc. are expected to contribute to the overall market growth. For instance, in April 2024, Molnlycke Health Care has announced its plans to acquire P.G.F. Industry Solutions GmbH, an Austrian company known for producing Granudacyn, a line of wound cleansing and moisturizing products.
U.S. Diabetic Foot Ulcer Treatment Market Report Highlights
- Based on treatment, the biologics segment dominated the market by capturing a revenue share of more than 30% in 2023
- The therapy devices segment is anticipated to grow at the fastest CAGR during the forecast period
- Based on ulcer type, the neuro-ischemic ulcers segment held the largest market share in 2023
- The Ischemic ulcers segment is expected to grow at a fastest rate from 2024 to 2030
- Based on end-use, hospitals and clinics led the market in 2023
- North America dominated the market in 2023
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. Diabetic Foot Ulcer Treatment Market Variables, Trends & Scope
Chapter 4. U.S. Diabetic Foot Ulcer Treatment Market: Treatment Estimates & Trend Analysis
Chapter 5. U.S. Diabetic Foot Ulcer Treatment Market: Ulcer Type Estimates & Trend Analysis
Chapter 6. U.S. Diabetic Foot Ulcer Treatment Market: End Use Estimates & Trend Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- ConvaTec, Group Plc
- 3M Health Care
- Coloplast Corp.
- Smith & Nephew Plc
- B Braun Melsungen AG
- Medline Industries, LP.
- Molnlycke Health Care AB
- Medtronic Plc
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 180 |
| Published | June 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 1.75 Billion |
| Forecasted Market Value ( USD | $ 2.47 Billion |
| Compound Annual Growth Rate | 5.2% |
| Regions Covered | United States |
| No. of Companies Mentioned | 8 |
